CoChat

Reduction of Sleep-disordered Breathing after Physostigmine

Hedner, Jan, Kraiczi, Holger, Peker, Yuksel, Murphy, Paul · 2003 · American Journal of Respiratory and Critical Care Medicine

The DOI matches its Crossref record; 36 of the 37 references it cites were found in a registry or an index.

Abstract

The cholinesterase inhibitor physostigmine (PHYS) was investigated in a double-blind, placebo-controlled, randomized, crossover trial of 10 male patients with moderate to severe obstructive sleep apnea. PHYS (0.12 μg/minute/kg, 7-hour infusion) reduced mean apnea/hypopnea index (AHI) by 13.6 (95% confidence interval [CI], 2.2–25.1) corresponding to 21.4% (95% CI, –5.5 to 47.9) and increased minimum SaO2 by 8.7% (95% CI, –0.3 to 17.7) corresponding to 23.2% (95% CI, 4.8–41.3). During the last third of the night, coinciding with predicted plasma concentration steady state, non-REM sleep AHI decreased by 19.2 (95% CI, 0.1–38.3) or 14.9% (95% CI, −43.6 to 77.7) and REM AHI by 33.8 (95% CI, 13.7–54.0) or 67.5% (95% CI, 49.7–85.3). Mean total sleep time was reduced by 74 minutes (95% CI, 33.9–114.9), but patients with the least pronounced sleep shortening had the largest reduction of AHI (r = 0.73, p < 0.02). The nocturnal decline in heart rate was reduced by PHYS. Moreover, resting (early-night placebo heart rate) was positively correlated with proportional reduction of REM apnea index (r = 0.69, p < 0.02). Body mass index was negatively correlated with reduction of REM AHI (r = 0.77, p < 0.02). This, predominantly REM-related, reduction of obstructive sleep apnea after PHYS may provide a new treatment option if the effects are maintained in long-term studies.

Overview

Integrity signals

Registry

Crossref · 10.1164/rccm.200211-1344oc

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 36 references

Research works printed but not linked: 37

  1. 1997, Sleep, 654
  2. 2000, Respir Physiol, 113
  3. 2000, Am J Respir Crit Care Med, 740
  4. 1992, Am Rev Respir Dis, 1246
  5. 1998, Am J Respir Crit Care Med, 586
  6. 1978, J Appl Physiol, 931
  7. 1989, Curr Pulmonol, 265
  8. 2000, Respir Physiol, 167
  9. 1998, CNS Drug Rev, 87
  10. 1996, Pharmacol Rev, 179
  11. 1978, Psychopharmacology (Berl), 111
  12. 2003, Neurology, 35
  13. 2002, Am J Respir Crit Care Med, A725
  14. 1992, Sleep, 174
  15. 1986, Acta Anaesthesiol Scand, 177
  16. 1999, J Pharm Biomed Anal, 939
  17. 1993, Clin Neuropharmacol, 61
  18. 1991, Clin Pharm, 447
  19. 1985, Pharmacologist, 396
  20. 1989, Biopharm Drug Dispos, 187
  21. 1987, Neuropharmacology, 831
  22. 1973, Neuropharmacology, 15
  23. 1986, Neurochem Res, 1037
  24. 1986, J Neural Transm, 275
  25. 1991, Drug Metab Dispos, 655
  26. 1997, Am J Physiol, R896
  27. 2002, Sleep, 307
  28. 1988, Psychiatry Res, 137
  29. 2000, Am J Respir Crit Care Med, 1606
  30. 2002, Respir Physiol Neurobiol, 135
  31. 2000, Respir Physiol, 111
  32. 2000, Adv Exp Med Biol, 485
  33. 1992, Respiration (Herrlisheim), 65
  34. 2001, Eur J Oral Sci, 371
  35. 1998, Am J Respir Crit Care Med, 1522
  36. 2002, N Engl J Med, 404
  37. 1996, Am J Respir Crit Care Med, 167

Cited by

See all 81

Metadata

Authors
Hedner, J., Kraiczi, H., Peker, Y., & Murphy, P.
Affiliations
  • Sahlgrenska University Hospital (SE)
  • Sleep Laboratory, Departments of Pulmonary Medicine and Clinical Pharmacology; and Sahlgrenska University Hospital, Göteborg, Sweden
Venue
American Journal of Respiratory and Critical Care Medicine
Published
2003-11
Volume
168
Issue
10
Pages
1246-1251
ISSN
  • 1073-449X (ISSN-L)
  • 1535-4970
OpenAlex
W2149626929
Cited by
81
References
37
Citations by year
2026: 2 · 2025: 1 · 2024: 3 · 2023: 2 · 2022: 4 · 2021: 2 · 2020: 2 · 2019: 3 · 2018: 1 · 2017: 2 · 2016: 4 · 2015: 5 · 2013: 5 · 2012: 6
FWCI
3.56
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Respiratory and Critical Care Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Physiology (medical) › Obstructive Sleep Apnea Research
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroscience of respiration and sleep
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
Keywords
physostigmine, obstructive sleep apnea, cholinesterase inhibitors, REM sleep apnea, apnea-hypopnea index, nocturnal oxygen saturation, heart rate variability, sleep duration, body mass index, sleep-disordered breathing
MeSH terms
Adult, Cholinesterase Inhibitors, Double-Blind Method, Humans, Male, Middle Aged, Physostigmine, Severity of Illness Index, Sleep, REM, Time Factors, Body Mass Index, Polysomnography, Cross-Over Studies, Sleep Apnea, Obstructive

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Reduction of Sleep-disordered Breathing after Physostigmine. https://app.cochat.ai/papers/10.1164/rccm.200211-1344oc
The paper
Hedner, J., Kraiczi, H., Peker, Y., & Murphy, P. (2003). Reduction of Sleep-disordered Breathing after Physostigmine. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.200211-1344oc

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.